Diabetes Care 2024: Pharmacologic Approaches to Glycemic Treatment
In the annual update of American Diabetes Association standards for diabetes care, the recommendations for pharmacotherapy now include a preference for insulin analogs or inhaled
In the annual update of American Diabetes Association standards for diabetes care, the recommendations for pharmacotherapy now include a preference for insulin analogs or inhaled
In the annual update of American Diabetes Association standards for diabetes care, the language used for obesity and weight management for the prevention and treatment
In its annual update of standards for diabetes care, the American Diabetes Association makes several key changes for the diverse population of older adults. For
In a nested case-control study of older Danish women with hysterectomy in 2000, estrogen-only therapy was associated with higher dementia rates. The relationship held “even
Clinical encounters for gender-affirming hormone therapy (GAHT) provide an opportunity to offer HIV testing and preexposure prophylaxis (PrEP) to transgender women (TGW) and transgender men
In the SURMOUNT-4 trial, withdrawal of tirzepatide led to rapid weight regain among participants with obesity or overweight, researchers report. In those who continued the
Treatment with metformin plus insulin people with preexisting type 2 or gestational diabetes diagnosed early in pregnancy did not reduce a composite neonatal adverse outcome
Two studies and an editorial explore the use of Janus kinase (JAK) inhibitors for preserving pancreatic β-cell function and preventing disease progression in type 1
Early reduction in albuminuria by finerenone accounts for “a large proportion of the treatment effect against CKD progression and a modest proportion of the effect
Wearable glucose sensors, automated insulin delivery (AID), and smartphone technology “illustrate how digital health technology can aid providers caring for patients with diabetes,” authors write